JAREX
Price
$13.80
Change
+$0.17 (+1.25%)
Updated
Apr 24 closing price
Net Assets
253.94M
MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
Ad is loading...

JAREX vs MGLIX

Header iconJAREX vs MGLIX Comparison
Open Charts JAREX vs MGLIXBanner chart's image
Easterly Global Real Estate A
Price$13.80
Change+$0.17 (+1.25%)
VolumeN/A
Net Assets253.94M
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
JAREX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JAREX vs. MGLIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAREX is a Buy and MGLIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. JAREX (254M). JAREX pays higher dividends than MGLIX: JAREX (2.89) vs MGLIX (2.61). JAREX was incepted earlier than MGLIX: JAREX (16 years) vs MGLIX (16 years). JAREX (1.46) is less costly to investors than MGLIX (0.95). JAREX is a more actively managed with annual turnover of: 141.00 vs. MGLIX (48.00). MGLIX has a lower initial minimum investment than JAREX: MGLIX (0) vs JAREX (2500). JAREX annual gain was more profitable for investors over the last year : 11.33 vs. MGLIX (2.35). MGLIX return over 5 years is better than : 21.58 vs. JAREX (10.82).
JAREXMGLIXJAREX / MGLIX
Total Expense Ratio1.460.94155%
Annual Report Gross Expense Ratio1.460.95154%
Fund Existence16 years16 years-
Gain YTD2.977-2.494-119%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets254M2.19B12%
Annual Yield % from dividends2.892.61111%
Returns for 1 year11.332.35483%
Returns for 3 years-15.30-21.1672%
Returns for 5 years10.8221.5850%
Returns for 10 years-18.2619.21-95%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5